Skip to main content
DXR logo

Daxor Corporation

DXRNASDAQHealthcareMedical Instruments & Supplies

$10.41
Today:- (-)1Y −17.45%

As of Oct 9, 2026 close

Market cap
$60.78M
P/E (TTM)
7.57
Forward P/E
4.55
Dividend yield
-
52-week range
$8.56$14.76
Volume (live)
-
Avg. volume (3M)
34.87K

Daxor (DXR) Stock Price & Financial Analysis

Daxor Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$10.41 - $10.71
52-Week High$14.76
52-Week Low$8.56
Open$10.51
Volume (last close)7.46K
Average Volume (3M)34.87K
Size & Valuation
Market Cap60.78M
Shares Outstanding5.84M
P/E Ratio (TTM)7.57
Forward P/E4.55
Price to Sales (P/S)69.98
Price to Book (P/B)1.17
EV/EBITDA5.74
Earnings & Profitability
Revenue (TTM)868.52K
Net Income (TTM)8.03M
Free Cash Flow (TTM)-2.84M
EPS (TTM)$1.61
Profit Margin924.10%
Operating Margin940.42%
Return on Equity (ROE)15.48%
Debt to Equity0.00
Technical Indicators
50-Day MA$10.66
200-Day MA$11.05
1-Year Change−17.45%
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateJan 5, 2018

Compare DXR with other stocks →

Daxor at a Glance

Daxor (DXR) has a market capitalization of $60.78M. The stock trades at 7.6× trailing earnings, 4.5× forward earnings and 70.0× sales. Over the trailing twelve months it earned $8.03M on revenue of $868.52K (a 924.1% profit margin) and burned $2.84M of free cash flow. Revenue fell 98.8% year over year.

It holds $5.79M in cash and securities against $0.00 of debt, a net cash position of $5.79M.

Daxor does not currently pay a dividend.

The share price is down 17.4% over the past year. At $10.41 it sits within its 52-week range of $8.56 to $14.76, below its 200-day moving average of $11.05.

Frequently Asked Questions About Daxor

What is the current stock price for DXR?

As of the Oct 9, 2026 close, DXR stock trades at $10.41. The 52-week range is $8.56–$14.76, with a day range of $10.41–$10.71.

What is the P/E ratio for DXR?

Daxor's trailing P/E ratio is 7.6, meaning investors pay $7.6 for every $1 of annual earnings. The forward P/E is 4.5, reflecting analyst expectations for future earnings. Daxor operates in the Healthcare sector.

Does DXR pay dividends?

Daxor does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DXR?

Analyst ratings and recommendations for DXR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of DXR?

Daxor's market capitalization is $60.8M, classifying it as a micro-cap company. Daxor operates in the Healthcare sector within the Medical Instruments & Supplies industry.